Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Artigo em Inglês | MEDLINE | ID: mdl-34473280

RESUMO

BACKGROUND: Vaporous hyperoxia therapy (VHT), a patented US Food and Drug Administration 510 (k)-cleared technology, is an adjunct therapy used in conjunction with standard wound care (SWC). Vaporous hyperoxia therapy is said to improve the health of wounded tissue by administering a low-frequency, noncontact, nonthermal, ionic, antimicrobial hydrating mist alternating with concentrated topical oxygen therapy. METHODS: Vaporous hyperoxia therapy was used to treat 36 subjects with chronic diabetic foot ulcers (DFUs) that were previously treated unsuccessfully with SWC. The average age of DFUs in the study was 11 months and the average size was over 3 cm2. Wounds were Wagner grade 2 or 3 and most commonly on the plantar surface around the midfoot. Treatment consisted of twice-weekly applications of VHT and wound debridement. Subjects were followed to wound closure, 20 weeks, or 40 treatments, whichever came first. RESULTS: The combination of SWC and VHT in the group that met and maintained compliance throughout the study period achieved an 83% DFU closure rate within a 20-week period. The average time for DFU closure in this study was 9.4 weeks. CONCLUSIONS: Historical analysis of SWC shows a 30.9% healing rate of all wounds, not differentiating chronic wounds. Accordingly, SWC/VHT increases chronic diabetic foot ulcer healing rates by 2.85 times compared with SWC alone. The purpose of this study was two-fold: first, to observe the effect of VHT on healing rates and time to healing in previously nonhealing DFUs; and second, to compare VHT with SWC, topical oxygen therapy, hyperbaric oxygen therapy, and ultrasound therapy.


Assuntos
Diabetes Mellitus , Pé Diabético , Úlcera do Pé , Hiperóxia , Humanos , Lactente , Pé Diabético/tratamento farmacológico , Cicatrização , Oxigênio/farmacologia , Oxigênio/uso terapêutico , Resultado do Tratamento
2.
J Foot Ankle Surg ; 56(1): 112-116, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-27600488

RESUMO

Marjolin's ulcer is a rare and aggressive cutaneous malignancy arising from previously traumatized skin, most commonly at the site of previous burns. We present a unique case of Marjolin's ulceration secondary to an orthopedic injury and a nonburn history of trauma. The patient had been involved in a motorcycle accident >20 years earlier. For 17 months, the patient had refused to acknowledge the severity of his disease state. He had refused the standard of care and opted for local wound care only until a minor fall caused a pathologic fracture, leading to an above the knee amputation. Road traffic incidents remain an uncommon cause of subsequent Marjolin's transformation in developed countries. As such, we present the case of a patient with a unique combination of a continued lack of compliance after diagnosis and the unusual cause of his initial trauma.


Assuntos
Amputação Cirúrgica/métodos , Carcinoma de Células Escamosas/patologia , Traumatismos da Perna/fisiopatologia , Úlcera da Perna/patologia , Neoplasias Cutâneas/patologia , Acidentes de Trânsito , Biópsia por Agulha , Carcinoma de Células Escamosas/fisiopatologia , Carcinoma de Células Escamosas/cirurgia , Doença Crônica , Progressão da Doença , Fêmur/cirurgia , Seguimentos , Humanos , Imuno-Histoquímica , Escala de Gravidade do Ferimento , Traumatismos da Perna/complicações , Traumatismos da Perna/diagnóstico por imagem , Úlcera da Perna/fisiopatologia , Úlcera da Perna/terapia , Masculino , Pessoa de Meia-Idade , Radiografia/métodos , Doenças Raras , Medição de Risco , Índice de Gravidade de Doença , Neoplasias Cutâneas/fisiopatologia , Neoplasias Cutâneas/cirurgia , Resultado do Tratamento , Recusa do Paciente ao Tratamento
3.
s.l; s.n; 1991. 8 p.
Não convencional em Inglês | Sec. Est. Saúde SP, HANSEN, Hanseníase, SESSP-ILSLACERVO, Sec. Est. Saúde SP | ID: biblio-1236620
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA